Advertisement

Topics

Aura Biosciences Announces Interim Phase 1b/2 Data on Light-Activated AU-011 for Primary Ocular ...

05:06 EST 11 Nov 2017 | BioMedReports - Blog

Data show that AU-011 was well-tolerated, patients had stable disease and vision was preserved

Read more...

Original Article: Aura Biosciences Announces Interim Phase 1b/2 Data on Light-Activated AU-011 for Primary Ocular ...

NEXT ARTICLE

More From BioPortfolio on "Aura Biosciences Announces Interim Phase 1b/2 Data on Light-Activated AU-011 for Primary Ocular ..."

Advertisement
Quick Search
Advertisement
Advertisement